Project description:Maternal obesity impacts neonatal outcomes; however, its influence on fetal gene expression and early gut microbiota composition remains insufficiently characterized. This prospective study was conducted in 62 full-term neonates between 2022 and 2024, analyzing transcriptomic profiles from umbilical-cord blood and metagenomic sequencing of fecal samples at 4 months. The cohort included 31 neonates born to mothers with normal BMI (NBMI) and 31 neonates born to mothers with overweight or obesity (OBMI). Major congenital anomalies, maternal exposure to drugs or antibiotics were exclusion criteria. OBMI neonates demonstrated significant upregulation of genes related to inflammation (MPO, OLR1) and cell-cycle dysregulation (GADD45G, CCNA1). Evidence of altered lysosomal function was observed, with increased expression of CTSG and CLTCL1 and reduced expression of HYAL1. Microbiome analysis revealed a decrease in Bacteroidota and an increase in Proteobacteria in cesarean-delivered neonates. Holdemanella was enriched in vaginally delivered OBMI neonates, suggesting a potential adaptive microbial response. Enrichment of opportunistic pathogens, including Klebsiella, Morganella, and Enterococcus, was observed in cesarean-delivered neonates, indicating a combined effect of maternal obesity and delivery mode on early microbial colonization. These findings suggest that maternal obesity modifies neonatal immune and metabolic gene expression while reshaping gut microbiome composition, with potential implications for long-term health.
Project description:This project investigates the impact of different delivery modes and labor on maternal and neonatal health by analyzing 40 participants, including 16 spontaneous vaginal deliveries (VD), 16 prelabor cesarean deliveries (CS), and 8 intrapartum cesarean sections (Intra_CS). Using label-free proteomics and untargeted metabolomics, both amniotic fluid and cord blood samples were analyzed respectively to identify variations in protein and metabolite profiles associated with the mode of delivery. The study aims to uncover biological pathways influenced by labor and delivery mode, providing insights into how these factors shape maternal and neonatal outcomes, with implications for improving perinatal care and long-term health strategies.
Project description:Premature birth and cesarean section are major perinatal factors influencing immune development and are associated with increased morbidity and inflammatory diseases. However, their impact on neonatal adaptive immunity remains incompletely understood. To determine how gestational age and mode of delivery shape early immune programming, we analyzed CD4⁺ T cells, central regulators of adaptive responses, from preterm neonates (28–36 wga) and full-term neonates delivered by cesarean section or natural birth. We performed transcriptomic profiling by mRNA sequencing, complemented by functional assessment of T cell activation, proliferation, and cytokine production following stimulation. The mode of delivery exerted a dominant effect on the CD4⁺ T cell transcriptome and function. CD4⁺ T cells from full-term neonates delivered by natural birth exhibited an immune activation signature compared with those from cesarean section and produced higher levels of multiple cytokines, but showed reduced proliferative capacity. In contrast, prematurity induced modest changes in basal gene expression relative to full-term cesarean section neonates. Despite these limited transcriptional differences, CD4⁺ Tcells from preterm neonates displayed enhanced proliferation and increased secretion of inflammatory cytokines IL-13, TNFα, IL-6, and IL-17F, indicating heightened responsiveness. Collectively, our findings suggest that CD4⁺ T cell immune programming begins in utero, as preterm neonates exhibit heightened inflammatory responsiveness. At term, the mode of delivery further refines this developmental trajectory. Cesarean section is associated with a restrained functional profile, whereas natural birth induces an immune activation signature and enhanced cytokine production. These results provide functional evidence that neonatal CD4⁺ T cell trajectories are established during fetal life and subsequently modulated at birth, underscoring the layered influence of perinatal factors on immune development.
Project description:<p><strong>Background: </strong>The gut microbiome, a complex community of bacteria, viruses, fungi, and protozoa, matures alongside its host. In humans, the birth mode, vaginal delivery (VD) or cesarean section (CS), is a major determinant of early microbial colonization. However, it remains unclear whether CS-associated colonization has lasting effects on microbiome-host interactions. To address this, we developed a Wistar rat model to examine how birth mode affects gut microbiome composition and the gut and plasma metabolome from weaning to adulthood.</p><p><br></p><p><strong>Methods: </strong>Male Wistar rats were assigned to three groups: (i) VD, born vaginally without cross-fostering; (ii) VD-CF, born vaginally and cross-fostered; and (iii) CS-CF, born via cesarean section followed by cross-fostering. Fecal samples were collected on postnatal days (PND) 25, 53, and 90 for microbiome profiling using 16S rRNA sequencing. Fecal and plasma samples collected on PND 25, 39, 53, 67, 81, and 90 were analysed by untargeted metabolomics.</p><p><br></p><p><strong>Results:</strong> The CS-CF group exhibited a distinct postnatal gut microbiome trajectory, characterized by lower α-diversity compared to VD and VD-CF animals, suggesting delayed microbial maturation. β-diversity analyses (unweighted and weighted UniFrac) revealed persistent birth mode-associated differences in microbial community composition, most pronounced in adulthood. Compositional analyses identified specific taxa altered by CS, including increased relative abundance of Romboutsia and Limosilactobacillus. Metabolomics analysis of fecal samples demonstrated clear differentiation between early (PND 25 and 39) and late (PND 53–90) postnatal stages in all groups with CS-CF animals showing a unique metabolic trajectory characterized by fewer temporal changes compared to VD and VD-CF groups. Specifically, the vaginal-delivered groups showed time-dependent increases in microbially derived metabolites, such as secondary bile acids and indole derivatives, a functional maturation profile that was absent in the CS-CF group.</p><p><br></p><p><strong>Conclusion:</strong> These findings indicate that cesarean section alters the postnatal development of the gut microbiome and metabolome, with potential long-term implications for host physiology. Importantly, this study establishes a Wistar rat model to investigate the causal effects of birth path on microbiome development and host metabolism, providing a valuable platform for future mechanistic and translational studies.</p>
Project description:National screening programs use dried blood specimens to detect abnormal metabolism or aberrant protein function in infants shortly after birth, thus identifying disorders that are not clinically evident in the newborn period. Gut microbiota metabolites and immunological acute phase proteins are capable of revealing potential immune aberrations. Microbial metabolites interact with xenobiotic receptors (i.e., aryl hydrocarbon and pregnane-X) and maintain gastrointestinal tissue health, supported by acute-phase proteins, functioning as sensors of microbial immunomodulation and homeostasis. The delivery mode (vaginal or cesarean section) shapes the microbial colonization, which substantially modulates both the immune system's response and mucosal homeostasis.
This study profiled microbial metabolites of the kynurenine and tryptophan pathway and acute phase proteins in 134 neonatal dried blood specimens. We newly established neonatal blood levels of the aryl hydrocarbon receptor microbial ligands (indole-3-aldehyde, indole-3-butyric acid, and indole-3-acetamide) on the second day of life. Furthermore, we observed divergent microbial metabolic profiles in neonates born vaginally or via cesarean section, hypothesizing potential microbial immunomodulatory influence. In summary, these findings suggest the supportive role of human gut microbiota in developing and maintaining immune system homeostasis.
Project description:<p>The Vaginal Microbiome Consortium team at Virginia Commonwealth University has conducted the Multi-Omic Microbiome Study: Pregnancy Initiative (MOMS-PI) in collaboration with the Global Alliance to Prevent Prematurity and Stillbirth (GAPPS) to better understand how microbiome and host profiles change throughout pregnancy and influence the establishment of the nascent microbiome in neonates. The team particularly focused on elucidation of the role of the microbiome and its components in the etiology of preterm birth, which occurs in over 10% of pregnancies and which is the leading cause of death in neonates. Samples from 1594 women and their neonates were collected throughout pregnancy, at delivery and postpartum. The group has generated a comprehensive dataset of multiple omics technologies. This longitudinal, large-scale effort was designed to provide a large-scale resource for the scientific community. The study also permits characterization of temporal dynamics of the microbiome in pregnancy and factors associated with preterm birth.</p>
Project description:Associations between antibiotic exposure intensity, intestinal microbiome perturbations, and outcomes in premature neonates with bacteremia
Project description:Clinical treatment protocols for infertility with in vitro fertilization-embryo transfer (IVF-ET) provide a unique opportunity to assess the human vaginal microbiome in defined hormonal milieu. Herein, we have investigated the association of circulating ovarian-derived estradiol (E2) and progesterone (P4) concentrations to the vaginal microbiome. Thirty IVF-ET patients were enrolled in this study, after informed consent. Blood was drawn at four time points during the IVF-ET procedure. In addition, if a pregnancy resulted, blood was drawn at 4-to-6 weeks of gestation. The serum concentrations of E2 and P4 were measured. Vaginal swabs were obtained in different hormonal milieu. Two independent genome-based technologies (and the second assayed in two different ways) were employed to identify the vaginal microbes. The vaginal microbiome underwent a transition with a decrease in E2 (and/or a decrease in P4). Novel bacteria were found in the vagina of 33% of the women undergoing IVF-ET. Our approach has enabled the discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu. While the relationship of hormone concentration and vaginal microbes was found to be complex, the data support a shift in the microbiome of the human vagina during IVF-ET therapy using standard protocols. The data also set the foundation for further studies examining correlations between IVF-ET outcome and the vaginal microbiome within a larger study population.